Get the Daily Brief
Latest Biotech News
Dual AI-Integrated Gene Therapy Platforms Forge High-Value Partnerships
Shape Therapeutics and VectorY Therapeutics announced a collaboration giving VectorY exclusive options to evaluate Shape's deep brain-penetrating AAV capsid technology, SHP-DB1, against multiple...
Advances in CRISPR and RNA Base Editing for Safer Gene Therapy
Researchers from UC San Diego and Yale have developed and highlighted small nuclear RNA base editing as a safer alternative to traditional CRISPR-Cas9 gene editing, addressing concerns of...
AI Model Predicts Risk of Over 1,000 Diseases Simultaneously
A novel generative AI model trained on data from the UK Biobank can forecast individual risk and timing of developing 1,258 diseases up to 20 years in advance. By integrating medical history with...
Breakthrough in Cancer Research: Targeting Pancreatic and Glioblastoma Tumors
Multiple studies unveiled novel molecular targets and mechanisms offering hope in combating lethal cancers. Indiana University researchers identified two proteins critical to pancreatic cancer's...
Emerging Biotech Startups Backed by Major Investors and Innovation Awards
New venture funds and leading startups are shaping the future of biotechnology. T.Rx Capital, co-founded by biotech veteran Robert Langer's son, announced a $77.5 million inaugural fund to invest...
Novel Therapies and Clinical Trial Updates in Metabolic and Autoimmune Diseases
Several early-stage therapeutic candidates and clinical results signal advances against obesity, diabetes, and autoimmune disorders. Hanmi Holdings presented preclinical data on HM-15275, a...
Advances in Imaging and Diagnostic Technologies
Innovative imaging and diagnostic tools continue to transform precision medicine. The Journal of Nuclear Medicine released cutting-edge molecular imaging studies that improve diagnostic accuracy....
Roche's $3.5B Bet on MASH Therapy 89bio
Roche has agreed to acquire 89bio in a deal totaling up to $3.5 billion, gaining access to pegozafermin, a phase 3-stage FGF21 analogue targeting metabolic dysfunction-associated steatohepatitis...
CDC Vaccine Panel Shifts Recommendations Under RFK Jr.
The CDC’s Advisory Committee on Immunization Practices (ACIP), reconstituted by Health Secretary Robert F. Kennedy Jr., voted to recommend that individuals 6 months and older should consult...
New CRISPR-Based and Genetic Editing Advances
Researchers from UC San Diego and Yale have developed safer genome editing technologies including small nuclear RNA base editing, an alternative to traditional CRISPR, which reduces unintended...
Advances in AI-Driven Biomedical Prediction and Diagnostics
A novel AI model trained on UK Biobank data can simultaneously forecast the risk of developing more than 1,000 diseases up to 20 years ahead, enabling comprehensive personalized risk prediction....
Novel Cancer Therapies and Biomarker Discoveries
Recent breakthroughs spotlight new therapeutic candidates and biomarkers in oncology. Regeneron reported a 100% response rate in a small smoldering multiple myeloma trial with its T-cell engager...
Breakthroughs in Cell Therapy and Immuno-oncology Platforms
Innovations in cell therapy manufacturing and immuno-oncology were highlighted by Cellares’ unveiling of its fully automated Cell Q quality control platform, designed to scale commercial cell...
Pediatric and Neonatal Health Insights
Recent pediatric studies have yielded critical insights into conditions ranging from preterm infant care to pediatric cancer. Researchers secured a $20.8 million NIAID grant to develop an HIV...
Innovations in Metabolic and Diabetes Therapeutics
Beijing QL Biopharmaceutical announced that its once-monthly GLP-1 receptor agonist, zovaglutide, achieved primary and secondary endpoints in a phase II obesity trial, demonstrating weight loss...
Cutting-Edge Neuro and Cardiovascular Research
Groundbreaking studies are reshaping the understanding of brain diseases and cardiovascular health. A pioneering study delineated new neural circuitry underlying autonomic dysreflexia in spinal...
Roche Accelerates Fatty Liver Disease Strategy with $3.5 Billion 89bio Acquisition
Roche has made a significant move in the metabolic and liver disease space by agreeing to acquire 89bio, a San Francisco-based biotech, in a deal worth up to $3.5 billion. The acquisition centers...
CDC Vaccine Advisory Panels Face Turmoil and Policy Shifts Under New Leadership
The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has encountered significant upheaval following the overhaul of members by Health and Human...
CRISPR and Gene Editing Innovations Drive Safer, More Precise Therapies
Groundbreaking advances in gene editing technologies continue to push the boundaries of precision medicine. Researchers at UC San Diego and Yale have developed small nuclear RNA base editing as a...
Artificial Intelligence Expands Predictive and Analytical Capabilities in Healthcare
New artificial intelligence models are dramatically enhancing disease prediction and biomedical analysis. The generative AI model Delphi-2M, trained on UK Biobank data, forecasts risk for over...